Skip to content

Nils Glagau, a DHDL investor, is looking to offload the Orthomol German operation for a reported 500 million euros.

German business Orthomol's sale desired by Nils Glagau for 500 million euros, as per Manager Magazine report.

Investor Nils Glagau intentions to offload Orthomol's German branch for a whopping 500 million...
Investor Nils Glagau intentions to offload Orthomol's German branch for a whopping 500 million euros.

Nils Glagau, a DHDL investor, is looking to offload the Orthomol German operation for a reported 500 million euros.

Here's a fresh, original take on the provided article:

Nils Glagau, the appearing shark on "The Lion's Den," recently announced that he's heading towards his swan song with the show, promising to participate in just two more episodes. As he prepares to call it quits, Glagau's focus seems to be shifting elsewhere - his nutritional supplement manufacturer, Orthomol.

Glagau, the current owner and CEO since 2009, is reportedly considering selling off the company he built, according to the Manager Magazine. The news has been buzzing for a few weeks now. But why the sudden change of heart?

A Second Bite at the Apple

Glagau attempted to sell Orthomol at the tail end of last year, but the deal fell through, allegedly due to pricing issues with an intended sale price of a whopping one billion euros. This time around, Glagau's got a different aim - he's only looking to sell a portion of the company, with the target price set at a more manageable 500 million euros.

But who's ready to shell out half a billion bucks for a piece of Orthomol? According to the Manager Magazine, one possible candidate could be the financial investor CVC Capital Partners - the same company that snatched up the vitamin startup Sunday Natural last year.

Heads Up - It's Anyone's Game

It's important to note that, as of now, the specific buyer or interested party in the sale of Orthomol hasn't been publicly revealed.Keep your eyes peeled for updates on the situation, as business news and official company communications could provide further insights.

As Nils Glagau plans to sell a portion of his company, Orthomol, for a target price of 500 million euros, financial investors like CVC Capital Partners, who recently acquired the vitamin startup Sunday Natural, could potentially make a bid. Meanwhile, the specific buyer or interested party in the sale hasn't been publicly announced, so it's anyone's game in the world of entrepreneurship and investing in the real-estate and business sectors.

Read also:

    Latest

    Rising rates, infrequent rent decreases, and strain on suppliers: Is crowdsourced financing the...

    Surging prices, seldom reductions in rent, and strained suppliers: Could crowdfunding be the solution to sustain family-owned guitar stores? A unique fundraising initiative from one such business aims to preserve its operations.

    Major music gear stores are experiencing financial hardships, leading to the closure of numerous establishments. Among these affected businesses, the UK's Hobgoblin Music, frequented by Paul McCartney, intends to defy the downturn in sales trends.